CNAT News and Press, Conatus Pharmaceuticals From 09/19/18

Money won't create success, the freedom to make it will - Nelson Mandela Investment Thesis Pfizer Inc. ( PFE ), a large-cap ($251B) multi-billion global biopharmaceutical company, gained pharmaceutical celebrity status when sildenafil citrate marketed globally as Viagra was app...

NEW YORK, NY / ACCESSWIRE / September 19, 2018 / U.S. markets closed up Tuesday on the strength of upbeat corporate earnings and strong economic data. On Tuesday, China announced tariffs of between 5 to 10 percent on $60 billion worth of U.S. in response to U.S. tariffs. The Dow Jones Indust...

SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has accepted invitations to participate in two upcoming investor conferences. At the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease (September 26-27 in New York), senior manage...